Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Low-molecular-weight heparin and survival in lung cancer.

Noble S.

Thromb Res. 2012 Apr;129 Suppl 1:S114-8. doi: 10.1016/S0049-3848(12)70029-4.

PMID:
22682120
2.

Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.

Nishioka J, Goodin S.

J Oncol Pharm Pract. 2007 Jun;13(2):85-97. Review.

PMID:
17873108
3.

[Heparin and cancer].

Lykke J.

Ugeskr Laeger. 2006 Dec 11;168(50):4397-401. Review. Danish.

PMID:
17217864
5.

Can low-molecular-weight heparins improve outcome in patients with cancer?

Thodiyil P, Kakkar AK.

Cancer Treat Rev. 2002 Jun;28(3):151-5. Review.

PMID:
12234567
6.

Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?

Ferretti G, Bria E, Giannarelli D, Carlini P, Felici A, Mandala M, Papaldo P, Nistico C, Fabi A, Cuppone F, Gelibter A, Terzoli E, Cognetti F.

J Clin Oncol. 2005 Oct 1;23(28):7248-50; author reply 7250. No abstract available.

PMID:
16192623
7.

Antithrombotic therapy with low molecular weight heparin in cancer patients.

Petralia P, Kakkar AK.

Eur J Med Res. 2004 Mar 30;9(3):119-24. Review.

PMID:
15096321
8.

Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?

Burris HA 3rd.

Semin Oncol. 2006 Apr;33(2 Suppl 4):S3-16; quiz S41-2. Review.

PMID:
16638456
9.

Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus location.

Prestidge T, Lee S, Harper P, Young L, Ockelford P.

Intern Med J. 2012 Jan;42(1):71-4. doi: 10.1111/j.1445-5994.2010.02401.x.

PMID:
21118408
11.
12.

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P, Farge D.

Arch Intern Med. 2002 Aug 12-26;162(15):1729-35.

PMID:
12153376
13.

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.

Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S.

J Thromb Haemost. 2004 Aug;2(8):1266-71.

14.

[Do anticoagulants improve survival in patients with cancer?].

Meyer G.

Pathol Biol (Paris). 2008 Jun;56(4):233-8. doi: 10.1016/j.patbio.2008.03.001. Epub 2008 May 5. French.

PMID:
18456421
15.

The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.

Cunningham RS.

Semin Oncol. 2006 Apr;33(2 Suppl 4):S17-25; quiz S41-2. Review.

PMID:
16638457
16.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
17.

Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?

Caine GJ, Lip GY.

Arch Intern Med. 2003 May 26;163(10):1243-4; author reply 1244. No abstract available.

PMID:
12767973
18.

Low-molecular-weight heparin and survival in patients with malignant disease.

Kakkar AK.

Cancer Control. 2005 Sep;12 Suppl 1:22-30. Review. No abstract available.

19.

Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.

Carrier M, Le Gal G, Cho R, Tierney S, Rodger M, Lee AY.

J Thromb Haemost. 2009 May;7(5):760-5. doi: 10.1111/j.1538-7836.2009.03326.x. Epub 2009 Feb 24.

20.

Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.

Macbeth F, Noble S, Evans J, Ahmed S, Cohen D, Hood K, Knoyle D, Linnane S, Longo M, Moore B, Woll PJ, Appel W, Dickson J, Ferry D, Brammer C, Griffiths G.

J Clin Oncol. 2016 Feb 10;34(5):488-94. doi: 10.1200/JCO.2015.64.0268. Epub 2015 Dec 23.

PMID:
26700124

Supplemental Content

Support Center